@official.justin.bucki's TRT claims need some context

What did @official.justin.bucki actually say?

The creator walked through a technique called "back loading" where you draw testosterone from a vial using a standard 20-gauge needle, then transfer the oil directly into the barrel of an insulin syringe by removing the plunger and shooting the oil in from behind. His main pitch: it "saved you five" minutes compared to pulling viscous oil through a narrow insulin needle tip.

To be fair, this is a real technique used in the self-injection community, particularly among people on daily subcutaneous testosterone protocols. He covered the basic mechanics accurately and mentioned keeping a sterile surface. He also warned about flipping the syringe to avoid pushing oil out the tip prematurely. The technique itself is not invented or fringe. But the video skips over some genuinely important considerations that a one-minute tutorial probably should not skip.

Does the science back this up?

The time-saving rationale is sound. The sterility concerns are real and underexplored in the video.

Pulling viscous testosterone oil through a 28-31 gauge insulin needle tip is genuinely slow and can introduce negative pressure issues and air bubbles. Back loading avoids that by bypassing the needle entirely during transfer. That part is mechanically logical and widely described in clinical self-injection literature.

However, the sterility risk of opening a syringe barrel is not trivial. A 2019 paper by Dolan et al. in the Journal of Diabetes Science and Technology documented contamination risks associated with insulin syringe manipulation, noting that any breach of the sealed barrel introduces pathogen exposure risk proportional to the environment and technique. The creator says "make sure you have a sterile surface" but does not elaborate. For immunocompromised patients or anyone injecting frequently, that casual framing may not be sufficient guidance. Clinical guidelines from the Endocrine Society (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism) emphasize aseptic technique for all injectable hormone therapies.

What did they get wrong (or right)?

He got the core mechanical logic right. He got the risk communication wrong.

The back-loading technique works. Removing the plunger, injecting oil from the back, and reinserting the plunger is a legitimate method used in harm reduction and self-injection communities. Credit where it is due.

What he glossed over:

• Opening a syringe barrel exposes the inside to ambient air and surface contaminants. "Sterile surface" in most home bathrooms or kitchens is not the same as a clinical sterile field.
• He does not mention wiping the tip of the transfer syringe or the insulin syringe barrel with alcohol before contact.
• There is no mention of how long a back-loaded syringe can safely sit before use, which matters for anyone pre-loading multiple doses.
• He says "0.2" as an example daily dose but does not clarify units. For a viewer new to testosterone injections, that ambiguity between 0.2 mL and 0.2 mg is not trivial.

None of this makes the technique dangerous if done carefully, but the one-minute framing undersells the attention the process requires.

What should you actually know?

Back loading is a real, widely-used method for transferring viscous oils into insulin syringes. It works. The risk is in execution, not concept.

If you are on a daily subcutaneous testosterone protocol prescribed through a telehealth or clinic program, the technique can reduce injection time significantly. But the aseptic steps matter more than the video implies. Use a clean, wiped-down surface. Swab contact points with 70 percent isopropyl alcohol. Do not pre-load syringes days in advance and leave them unsealed. Testosterone cypionate and enanthate in oil are relatively resistant to microbial growth, but that does not mean sterility is optional.

Also worth knowing: daily subcutaneous injections are used by some clinicians to minimize testosterone peaks and troughs compared to less frequent intramuscular dosing. A 2021 study by Ramasamy et al. in The Journal of Urology found that subcutaneous testosterone produced stable serum levels with acceptable tolerability. Whether daily versus two to three times weekly is better for a given patient depends on individual pharmacokinetics, not a general preference.

If you are new to testosterone injections, this video is not a substitute for training from a prescribing clinician or pharmacist. The technique is fine. The shortcuts in the explanation are not.